Rimegepant Shows Promise for Relief From Migraine Attacks
Increase seen in percentage of patients free from pain, from their most bothersome symptom at two hours
Exposure to 2009 pH1N1 Vaccine During Pregnancy Seems Safe
Exposure to pH1N1 influenza vaccine in utero not linked to most pediatric health outcomes
High Incarceration Rates Tied to More Drug-Related Deaths
Findings based on U.S. county-level data, independent of opioid prescription rates
Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
Incidence of herpes zoster decreased during median 21-month follow-up after autologous HSCT
About 12 Percent With Ankle Sprain Fill Opioid Prescriptions
Among opioid-naive patients, 8.4 percent of those who filled an initial opioid Rx had persistent use
Guidance Updated for Managing Infants at Risk for Group B Strep
Risk assessment should consider infants born at ≥35 0/7 weeks and ≤34 6/7 weeks separately
Two Algorithms Can ID Patients at Risk for HIV, PrEP Candidates
Algorithms use data from EHRs to identify candidates for preexposure prophylaxis
Galcanezumab Can Cut Frequency of Cluster Headache Attacks
Mean reduction in weekly frequency of cluster headache attacks greater with galcanezumab versus placebo
Lab Tests Show Experimental Ebola Treatments Effective
Remdesivir, ZMapp monoclonal antibodies both appear to block growth of the Ebola virus strain
History of Liver Disease Does Not Impact Efficacy of Edoxaban
Patients with a-fib and history of liver disease more often had major bleeding but no increase in SSEE
